Phase II proof of concept study of Hydrocortisone (Chronocort®) in patients with adrenal-insufficiency.
Phase of Trial: Phase II
Latest Information Update: 16 Mar 2018
Price : $35 *
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Adrenal insufficiency
- Focus Proof of concept; Therapeutic Use
- Sponsors Diurnal
- 16 Mar 2018 New trial record
- 12 Mar 2018 According to the Diurnal media release, this trial is expected to commence around the end of 2018.